AMIGO2 is involved in the spread of peritoneal metastasis in serous ovarian cancer via promoting adhesion to the peritoneal mesothelial cells Yuki IidaMitsuhiko OsakiFutoshi Okada Original Article 29 May 2024
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy Kazuyuki NumakuraYuya SekineTomonori Habuchi Original Article 26 May 2024
Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan Tatsuro YamaguchiMasachika IkegamiHideyuki Ishida Original Article 25 May 2024
CT-derived skeletal muscle change before immunotherapy predicts survival of advanced gastric cancer: associations with inflammatory markers and liver lipid metabolism Koichi HayanoGaku OhiraHisahiro Matsubara Original Article Open access 22 May 2024
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study Shuhei HaraKeiichiro MoriTakahiro Kimura Original Article 20 May 2024
New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm Ryosuke FukushimaNorifumi HarimotoKen Shirabe Original Article 20 May 2024
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models Reika Kawabata-IwakawaNorihiro IwasaMasahiko Nishiyama Original Article 20 May 2024
Trends in incidence and hormonal management of endometrial cancer during potentially reproductive age in Japan: a population-based study Tomoyuki SasanoSeiji MabuchiIsao Miyashiro Original Article 19 May 2024
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study Kaname NosakiKiyotaka YohKoichi Goto Original Article 17 May 2024
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology Yuho NajimaTomoya MaedaShingo Yano Special Article 17 May 2024
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis Hirotoshi IiharaMasakazu AbeKenjiro Aogi Special Article Open access 16 May 2024
Treatment strategy for HER2-negative advanced gastric cancer: salvage-line strategy for advanced gastric cancer Naohiro NishidaDaisuke SakaiTaroh Satoh Invited Review Article Open access 11 May 2024
Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer Yusuke SeikiKenji IkezawaKazuyoshi Ohkawa Original Article 10 May 2024
Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma Ryoko TanakaYushi UekiArata Horii Original Article 10 May 2024
Genomic medicine advances for brain tumors Shinichiro KoizumiTomoya OishiKazuhiko Kurozumi Invited Review Article 10 May 2024
The efficacy and safety of anamorelin among patients with diabetes Kenju AndoTateaki NaitoToshiaki Takahashi Original Article 09 May 2024
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 Masamitsu KobayashiJun KakoKeiko Iino Special Article 09 May 2024
Risk factors for lymph node metastasis in T2 colorectal cancer: a systematic review and meta-analysis Jun WatanabeKatsuro IchimasaKhay Guan Yeoh Review Article 06 May 2024
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology Kenji TsuchihashiMamoru ItoEishi Baba Special Article 02 May 2024 Pages: 700 - 705
Prognostic value of a mandibular canal staging system for primary lesions in patients with lower gingival squamous cell carcinoma: a multicenter, retrospective study Nobuhiro YamakawaMasaya OkuraJapan Oral Oncology Group (JOOG) Original Article 02 May 2024
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of elranatamab for multiple myeloma, CPX-351 for myeloid leukemia, inotuzumab ozogamicin for lymphoblastic leukemia, capivasertib for breast cancer, and zolbetuximab for gastric cancer in Japan Noriomi MatsumuraMasaki Mandai PMDA Regulatory Update 30 April 2024
Relationship between HER2-low status and efficacy of CDK4/6 inhibitors in advanced breast cancer: a real-world study T. ÖnderÖ. AteşC. Karaçin Original Article 30 April 2024
Optimal surgical approach for mid-transverse colon cancer: a systematic review and meta-analysis Beshoy Effat ElkomosPhilopateer Effat AlkomosAyman Hossam eldin Abd el monaem Ali Review Article Open access 29 April 2024 Pages: 706 - 715
Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer Ryosuke FukushimaNorifumi HarimotoKen Shirabe Original Article 29 April 2024
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study Sho SatoTakashi SsuzukiHideaki Shimada Original Article 28 April 2024
Availability of genome-matched therapy based on clinical practice Naomi HayashiSeiichi MoriShunji Takahashi Original Article Open access 26 April 2024
Significance of radiation therapy in the myxoid round-cell liposarcoma treatment regimen Akiyoshi ShimataniHirohisa KatagiriTsuyoshi Onoe Original Article 24 April 2024
SlicerPIT: software development and implementation for planning and image-guided therapy in photoimmunotherapy Takayoshi SuzukiSatoshi KanoAkihiro Homma Original Article 23 April 2024 Pages: 735 - 743
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022 Tetsuhiro YoshinamiKazuki NozawaToshimi Takano Special Article 23 April 2024 Pages: 681 - 688
Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis Guoqiang XueZhen WangChunyi Hao Original Article 23 April 2024
Biomarker-oriented chemo-immunotherapy for advanced gastric cancer Koji KonoShotaro NakajimaKosaku Mimura JSCO Board of Directors Series 22 April 2024
Clinicopathological characteristics of Lynch-like syndrome Sakiko NakamoriMisato TakaoTatsuro Yamaguchi Original Article 20 April 2024
A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer Katsumasa NakamuraKeiji NiheiYoshikazu Kagami Original Article 17 April 2024 Pages: 847 - 852
New therapeutic target molecules for gastric and gastroesophageal junction cancer Hisato Kawakami Invited Review Article 17 April 2024
Early experience and future prospects regarding use of newly developed surgical robot system, hinotori, in the field of urologic cancer surgery Hideaki MiyakeMasato Fujisawa JSCO Board of Directors Series Open access 16 April 2024 Pages: 640 - 646
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval of nivolumab for unresectable advanced or recurrent epithelial skin malignancies in Japan Noriomi MatsumuraMasaki Mandai PMDA Regulatory Update 16 April 2024 Pages: 639 - 639
Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers Ayaka KatayamaYuki AokiTetsunari Oyama Invited Review Article 15 April 2024
Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome Tetsuya ItoTatsuro YamaguchiHideyuki Ishida Original Article Open access 14 April 2024
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology Seiichi HirotaUkihide TateishiMembers of the Systematic Review Team of the Present Guidelines Special Article Open access 13 April 2024 Pages: 647 - 680
Progressive changes in the protein expression profile of alveolar septa in early-stage lung adenocarcinoma Toru KimuraTakashi AkazawaJiro Okami Original Article 11 April 2024 Pages: 771 - 779
Preoperative predictive factors for positive peritoneal cytology results in patients with pancreatic ductal adenocarcinomas: a retrospective study Gaku ShimaneYutaka NakanoYuko Kitagawa Original Article 10 April 2024
Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy Kazushige KawaiKosuke OzakiSoichiro Ishihara Original Article 09 April 2024
Psoas mass index at the level of the third lumbar vertebra on computed tomography is a prognostic predictor for metastatic castration-sensitive prostate cancer Shunsuke OwaTakeshi SasakiTakahiro Inoue Original Article 08 April 2024 Pages: 840 - 846
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab Takeru WakatsukiNaoki IshizukaDaisuke Takahari Original Article Open access 08 April 2024 Pages: 801 - 812
Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database Chuyue ZhangBin LiYan Yang Original Article Open access 07 April 2024 Pages: 744 - 754
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors Hirotaka NagasakaTakeshi KishidaTetsuro Sasada Original Article Open access 06 April 2024 Pages: 832 - 839
Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis Akihiro MatsukawaPawel RajwaTakafumi Yanagisawa Review Article Open access 06 April 2024 Pages: 716 - 725
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology Mamoru ItoYuta OkumuraKenji Tsuchihashi Special Article 05 April 2024 Pages: 689 - 699
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy Taha Koray SahinYakup OzbayOmer Dizdar Original Article 02 April 2024 Pages: 822 - 831
Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial Motohiro MatsuiAtsushi MakimotoYuki Yuza Original Article 02 April 2024 Pages: 629 - 637
